
Eisai Investor Relations Material
Latest events

Status Update
Eisai
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Eisai Co Ltd
Access all reports
Eisai Co., Ltd. is a global pharmaceutical company based in Tokyo, Japan. The company focuses on the research and development, manufacturing, and marketing of prescription medicines. Eisai's business activities extend to the discovery, development, manufacture, and sale of pharmaceuticals, including a broad range of therapeutic areas such as neurology and oncology. Eisai is headquartered in Bunkyo-ku, Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.
Key slides for Eisai Co Ltd


Q4 2025
Eisai Co Ltd


Q1 2026
Eisai Co Ltd
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
4523
Country
🇯🇵 Japan